Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Ijeoma Uchegbu
29 - 39 Brunswick Square
Tel: + 44 207 753 5997
Fax: + 44 207 753 5942
  • Professor
  • Pharmaceutics
  • UCL School of Pharmacy
  • Faculty of Life Sciences

Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience within the UCL School of Pharmacy.  She obtained her PhD from the School of Pharmacy in 1994 and was appointed to a lectureship in Drug Delivery in 1997 within the University of Strathclyde.  She became a senior lecturer in 2000 and a Professor of Drug Delivery in 2002.  She then joined the School of Pharmacy as a Professor of Pharmaceutical Nanoscience in 2006 and joined UCL in 2012.  In 2010 Ijeoma became cofounder Chief Scientific Officer of Nanomerics Ltd, a specialty pharmaceutical company and spin out from UCL.  Ijeoma has won numerous prizes for her work including the UK's Department of Business Innovation and Skills' Women of Outstanding Achievement Award in 2007 and the Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award in 2012.

Research Groups
Research Themes
Research Summary

Research in the Pharmaceutical Nanoscience group exploits fundamental physical chemistry principles to fabricate functional pharmaceutical nanoparticles - nanomedicines.  Our output stretches seamlessly from molecular design of functional pharmaceutical excipients to the dosage form's in vivo characteristics.  Our group designs and synthesises polymers which self assemble into tailored nanoparticles with the predictable, morphology, size, drug loading and drug transport properties.  We have been successful in designing pharmaceutical nanosystems which deliver: genes and siRNA to tumours, peptides to the brain via the oral and intravenous routes and nanoparticles facilitate the oral absorption of hydrophobic drugs.  Our work is being commercialised via a UCL spin out company - Nanomerics Ltd. 

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by